OrganOx announced today that it completed a $142 million primary and secondary equity financing to accelerate growth opportunities. New investor HealthQuest Capital led the oversubscribed funding round. Existing investors BGF and Lauxera Capital Partners, with new investors Sofina, Soleus Capital and Avidity Partners participated, too. OrganOx’s investors also include the University of Oxford, Technikos, the […]
Transplants
Getinge to phase out its surgical perfusion business
Getinge has initiated a gradual phaseout of its surgical perfusion business, to focus on more profitable growth areas such as extracorporeal life support (ECLS) and transplant care. During a Jan. 28 earnings call, Getinge CEO Mattias Vadsten described surgical perfusion — technology that temporarily supports or replaces a patient’s heart and lungs during surgery — […]
TransMedics faces fraud, organ trafficking accusations from activist short seller
TransMedics (Nasdaq: TMDX) is facing allegations of fraud, organ trafficking, and unethical practices that have triggered shareholder investigations. The claims, detailed in a report by short-seller Scorpion Capital, have triggered investigations by two shareholder rights law firms. In response, TransMedics has issued a strong denial, calling the report inaccurate and misleading. On January 10, Scorpion […]
FDA greenlights expansion of BiVacor artificial heart study
BiVacor announced today that it completed the first phase of an FDA early feasibility study (EFS) for its Total Artificial Heart (TAH). Five patients received the BiVacor TAH between July and November 2024 in the study looking at the TAH as a bridge to donor heart transplant. The initial phase supported patients with the TAH […]
Paragonix Technologies announces first-in-human use of PancreasPak organ preservation system
Paragonix Technologies today announced the world’s first successful human use of its PancreasPak Organ Preservation System. The technology was used at Tampa General Hospital Transplant Institute in a recent pancreas transplant, advancing efforts to enhance organ preservation for better transplant outcomes. Dr. Matthew Hunter Witt, a transplant surgeon at Tampa General Hospital, led the case. […]
FDA clears Paragonix KidneyVault portable renal perfusion system
Paragonix Technologies this week announced it received FDA 510(k) clearance for its KidneyVault donor kidney preservation system. KidneyVault is Paragonix’s first perfusion device. The company designed it to streamline digital monitoring capabilities with portable hypothermic perfusion technology to help protect donor kidneys during transport. The system also expands the kidney donor pool. Paragonix said it […]
Paragonix announces first pediatric use of BAROguard lung preservation system
Paragonix today announced the first pediatric use of its BAROguard Donor Lung Preservation System in a lung transplant case. The donor lungs were successfully implanted by Dr. Mindaugas Rackauskas and Dr. Mark Bleiweis at UF Shands Children’s Hospital in Gainesville, Florida. The system won FDA clearance in August 2023 and commercially launched in April. “UF […]
Paragonix expands liver transplant registry
Paragonix today announced a significant expansion of its GUARDIAN-Liver clinical registry with the appointment of a new principal investigator. The Waltham, Massachusetts-based organ transplant technology developer — which Getinge acquired for $477 million last month — now has more than 500 enrollments in its clinical registry for its liver preservation and transport technologies. With this […]
Getinge completes $477M Paragonix acquisition
Getinge today announced that it completed its previously announced acquisition of Paragonix Technologies for up to $477 million. Last month, the companies inked a definitive agreement under which Getinge would acquire the Massachusetts-based organ transplant technology developer. Getinge expects the deal to enhance its global healthcare portfolio while addressing needs in solid organ transplantation. Additionally, […]
Getinge to acquire organ preservation tech company Paragonix for $477M
Paragonix and Getinge announced a definitive agreement under which Getinge acquires the organ transplant technology developer. The total price of the acquisition, including upfront and earnout payments, could reach approximately $477 million. Getinge expects the deal to enhance its global healthcare portfolio while addressing needs in solid organ transplantation. The Sweden-based company can expand access to […]
Paragonix reports first pediatric use of liver preservation system
Paragonix Technologies today announced the first liver transplant case preserving a pediatric donor liver with the Liverguard preservation system. Dr. Deepak Vikraman successfully transplanted the donor liver at Duke University Hospital in Durham, North Carolina. “This case exemplifies the importance of employing the latest innovations in transplant preservation within pediatric care,” said Vikraman. “New technologies […]
